<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Topical Dermatological Generic Drug Products: Overcoming Barriers to Development and Improving Patient Access; Public Workshop; Request for Comments</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Topical Dermatological Generic Drug Products: Overcoming Barriers to Development and Improving Patient Access; Public Workshop; Request for Comments</h1>
    <p class="timestamp">Published: 2017-10-03 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "Topical Dermatological Generic Drug Products: Overcoming Barriers to Development and Improving Patient Access." The purpose of the public workshop is to provide an overview of current regulatory science initiatives related to generic topical dermatological drug products, solicit public input on scientific barriers that may limit patient access to such drug products, and discuss approac...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2017-21186</p>
    <p><strong>Publication Date:</strong> 2017-10-03</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2017/10/03/2017-21186/topical-dermatological-generic-drug-products-overcoming-barriers-to-development-and-improving">https://www.federalregister.gov/documents/2017/10/03/2017-21186/topical-dermatological-generic-drug-products-overcoming-barriers-to-development-and-improving</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2017-21186</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
